Barry Jones
Keine laufenden Positionen mehr
Profil
Barry Jones has served as Senior Vice President of Research since January 2003 and as Vice President of Research since March 2002, the date of the merger with Point Massachusetts and as Vice President of Research of Point Massachusetts since January 2000, and Director of Immunology of Point Massachusetts since 1997.
Prior to joining Point Massachusetts, he was Director of Immunology at Procept, Inc., from 1993 through July 1997.
He has also held academic research positions at Yale University's School of Medicine and at Pennsylvania State University.
Ehemalige bekannte Positionen von Barry Jones
| Unternehmen | Position | Ende |
|---|---|---|
Point Therapeutics, Inc.
 Point Therapeutics, Inc. BiotechnologyHealth Technology Point Therapeutics, Inc. develops drugs for the treatment of cancer and blood cell disorders. The company's PT-100 (talabostat) treats anemia and neutropenia (low levels of white blood cells), which can be caused by diseases or medical treatments, such as chemotherapy. The drugs stimulate production of proteins that build up the body's immune system against malignant tumors. Point Therapeutics, Inc. is located in Boston, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Procept, Inc.
 Procept, Inc. Pharmaceuticals: MajorHealth Technology Procept is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system disorders. Procept is developing therapeutics for the treatment of autoimmune disease, organ transplant rejection and infectious diseases, such as AIDS and tuberculosis. The company is located in San Diego. CA | Corporate Officer/Principal | - |
| ALAUNOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 22.10.2009 |
Ausbildung von Barry Jones
| Northeastern University | Undergraduate Degree |
| University of Bristol | Doctorate Degree |
| The University of Liverpool | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Point Therapeutics, Inc.
Point Therapeutics, Inc. BiotechnologyHealth Technology Point Therapeutics, Inc. develops drugs for the treatment of cancer and blood cell disorders. The company's PT-100 (talabostat) treats anemia and neutropenia (low levels of white blood cells), which can be caused by diseases or medical treatments, such as chemotherapy. The drugs stimulate production of proteins that build up the body's immune system against malignant tumors. Point Therapeutics, Inc. is located in Boston, MA. | Health Technology |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Procept is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system disorders. Procept is developing therapeutics for the treatment of autoimmune disease, organ transplant rejection and infectious diseases, such as AIDS and tuberculosis. The company is located in San Diego. CA | Health Technology |
